These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 718783)

  • 1. Pancuronium pharmacokinetics in patients with liver cirrhosis.
    Duvaldestin P; Agoston S; Henzel D; Kersten UW; Desmonts JM
    Br J Anaesth; 1978 Nov; 50(11):1131-6. PubMed ID: 718783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic and renal disposition of pancuronium and gallamine in patients with extrahepatic cholestasis.
    Westra P; Vermeer GA; de Lange AR; Scaf AH; Meijer DK; Wesseling H
    Br J Anaesth; 1981 Apr; 53(4):331-8. PubMed ID: 7225266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition kinetics of pancuronium bromide in patients with total biliary obstruction.
    Somogyi AA; Shanks CA; Triggs EJ
    Br J Anaesth; 1977 Nov; 49(11):1103-8. PubMed ID: 588390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of pancuronium bromide.
    Somogyi AA; Shanks CA; Triggs EJ
    Eur J Clin Pharmacol; 1976 Sep; 10(5):367-72. PubMed ID: 789085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC45) and pancuronium in anesthetized humans.
    Cronnelly R; Fisher DM; Miller RD; Gencarelli P; Nguyen-Gruenke L; Castagnoli N
    Anesthesiology; 1983 May; 58(5):405-8. PubMed ID: 6132566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC 45) in patients with cirrhosis.
    Lebrault C; Berger JL; D'Hollander AA; Gomeni R; Henzel D; Duvaldestin P
    Anesthesiology; 1985 May; 62(5):601-5. PubMed ID: 2859815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fazadinium pharmacokinetics in patients with liver disease.
    Duvaldestin P; Saada J; Henzel D; Saumon G
    Br J Anaesth; 1980 Aug; 52(8):789-94. PubMed ID: 6107098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of experimental cholestasis on neuromuscular blocking drugs in cats.
    Westra P; Houwertjes MC; de Lange AR; Scaf AH; Hindriks FR; Agoston S
    Br J Anaesth; 1980 Aug; 52(8):747-57. PubMed ID: 7426252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothermia and the pharmacokinetics and pharmacodynamics of pancuronium in the cat.
    Miller RD; Agoston S; van der Pol F; Booij LH; Crul JF; Ham J
    J Pharmacol Exp Ther; 1978 Nov; 207(2):532-8. PubMed ID: 712635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancuronium and vecuronium pharmacokinetics and pharmacodynamics in younger and elderly adults.
    Rupp SM; Castagnoli KP; Fisher DM; Miller RD
    Anesthesiology; 1987 Jul; 67(1):45-9. PubMed ID: 2886080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of Org NC 45 in man.
    van der Veen F; Bencini A
    Br J Anaesth; 1980; 52 Suppl 1():37S-41S. PubMed ID: 6107104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of renal failure on the disposition and neuromuscular blocking action of pancuronium bromide.
    Somogyi AA; Shanks CA; Triggs EJ
    Eur J Clin Pharmacol; 1977 Aug; 12(1):23-9. PubMed ID: 332502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of the pharmacodynamic interaction between pancuronium and mivacurium.
    Beaussier M; Deriaz H; De Traverse A; Abdelhalim Z; Lienhart A
    Br J Anaesth; 1998 Aug; 81(2):251-2. PubMed ID: 9813534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of different anesthetics on the pharmacokinetics and pharmacodynamics of pancuronium in the cat.
    Miller RD; Agoston S; van der Pol F; Booij LH; Crul JF
    Acta Anaesthesiol Scand; 1979 Jun; 23(3):285-90. PubMed ID: 484185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacodynamic model for pancuronium.
    Hull CJ; Van Beem HB; McLeod K; Sibbald A; Watson MJ
    Br J Anaesth; 1978 Nov; 50(11):1113-23. PubMed ID: 718781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of pancuronium in man: a linear system.
    Duvaldestin P; Demetriou M; D'Hollander A
    Eur J Clin Pharmacol; 1982 Oct; 23(4):369-72. PubMed ID: 7173308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic modelling with pancuronium.
    Evans MA; Shanks CA; Brown KF; Triggs EJ
    Eur J Clin Pharmacol; 1984; 26(2):243-50. PubMed ID: 6723764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients.
    Sohn YJ; Bencini AF; Scaf AH; Kersten UW; Agoston S
    Anesth Analg; 1986 Mar; 65(3):233-9. PubMed ID: 2869721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of pipecuronium in patients with cirrhosis.
    D'Honneur G; Khalil M; Dominique C; Haberer JP; Kleef UW; Duvaldestin P
    Anesth Analg; 1993 Dec; 77(6):1203-6. PubMed ID: 8250313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative potency and pharmacokinetics of pancuronium and its metabolites in anesthetized man.
    Miller RD; Agoston S; Booij LH; Kersten UW; Crul JF; Ham J
    J Pharmacol Exp Ther; 1978 Nov; 207(2):539-43. PubMed ID: 712636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.